Russell Investments Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-34,201
| Closed | -$4.38M | – | 4152 |
|
|
2025
Q2 | $4.38M | Sell |
34,201
-134,914
| -80% | -$14M | 0.01% | 1297 |
|
|
2025
Q1 | $15M | Buy |
169,115
+43,213
| +34% | +$4.22M | 0.02% | 673 |
|
|
2024
Q4 | $11M | Buy |
125,902
+16,874
| +15% | +$1.55M | 0.02% | 769 |
|
|
2024
Q3 | $10.1M | Buy |
109,028
+52,535
| +93% | +$5.22M | 0.01% | 833 |
|
|
2024
Q2 | $6.09M | Sell |
56,493
-1,221
| -2% | -$122K | 0.01% | 1051 |
|
|
2024
Q1 | $5.47M | Buy |
57,714
+17,712
| +44% | +$1.52M | 0.01% | 1126 |
|
|
2023
Q4 | $3.69M | Sell |
40,002
-58,678
| -59% | -$3.8M | 0.01% | 1286 |
|
|
2023
Q3 | $4.96M | Buy |
98,680
+27,200
| +38% | +$1.45M | 0.01% | 1084 |
|
|
2023
Q2 | $4.52M | Sell |
71,480
-19,046
| -21% | -$1.04M | 0.01% | 1145 |
|
|
2023
Q1 | $4.07M | Buy |
90,526
+28,340
| +46% | +$1.28M | 0.01% | 1196 |
|
|
2022
Q4 | $2.72M | Sell |
62,186
-7,540
| -11% | -$362K | 0.01% | 1400 |
|
|
2022
Q3 | $4.59M | Buy |
69,726
+3,510
| +5% | +$225K | 0.01% | 1094 |
|
|
2022
Q2 | $3.34M | Buy |
66,216
+32,917
| +99% | +$1.93M | 0.01% | 1306 |
|
|
2022
Q1 | $2.13M | Sell |
33,299
-11,125
| -25% | -$799K | ﹤0.01% | 1616 |
|
|
2021
Q4 | $4.76M | Sell |
44,424
-10,664
| -19% | -$1.12M | 0.01% | 1278 |
|
|
2021
Q3 | $5.66M | Sell |
55,088
-5,026
| -8% | -$468K | 0.01% | 1173 |
|
|
2021
Q2 | $5.28M | Buy |
60,114
+26,800
| +80% | +$2.46M | 0.01% | 1310 |
|
|
2021
Q1 | $3.24M | Sell |
33,314
-2,751
| -8% | -$275K | 0.01% | 1589 |
|
|
2020
Q4 | $4.05M | Sell |
36,065
-3,600
| -9% | -$379K | 0.01% | 1350 |
|
|
2020
Q3 | $3.67M | Buy |
39,665
+3,329
| +9% | +$256K | 0.01% | 1318 |
|
|
2020
Q2 | $2.83M | Sell |
36,336
-7,737
| -18% | -$523K | 0.01% | 1432 |
|
|
2020
Q1 | $2.58M | Buy |
44,073
+43
| +0.1% | +$2.77K | 0.01% | 1335 |
|
|
2019
Q4 | $3.53M | Buy |
44,030
+14,777
| +51% | +$1.11M | 0.01% | 1422 |
|
|
2019
Q3 | $2.15M | Buy |
29,253
+9,661
| +49% | +$835K | ﹤0.01% | 1640 |
|
|
2019
Q2 | $1.85M | Sell |
19,592
-3,590
| -15% | -$296K | ﹤0.01% | 1716 |
|
|
2019
Q1 | $1.85M | Hold |
23,182
| – | – | ﹤0.01% | 1757 |
|
|
2018
Q4 | $1.25M | Sell |
23,182
-3,071
| -12% | -$187K | ﹤0.01% | 1829 |
|
|
2018
Q3 | $2.05M | Buy |
26,253
+5,520
| +27% | +$384K | ﹤0.01% | 1737 |
|
|
2018
Q2 | $1.31M | Sell |
20,733
-3,741
| -15% | -$298K | ﹤0.01% | 1973 |
|
|
2018
Q1 | $2.24M | Buy |
24,474
+7,186
| +42% | +$619K | ﹤0.01% | 1772 |
|
|
2017
Q4 | $1.34M | Sell |
17,288
-7,598
| -31% | -$535K | ﹤0.01% | 2005 |
|
|
2017
Q3 | $1.73M | Sell |
24,886
-8,566
| -26% | -$458K | ﹤0.01% | 1868 |
|
|
2017
Q2 | $1.7M | Buy |
33,452
+22,890
| +217% | +$972K | ﹤0.01% | 1825 |
|
|
2017
Q1 | $422K | Sell |
10,562
-402
| -4% | -$14.4K | ﹤0.01% | 2486 |
|
|
2016
Q4 | $305K | Buy |
+10,964
| New | +$330K | ﹤0.01% | 2617 |
|
Other funds holding BPMC
IA
HNB
Russell Investments Group's BPMC Position: Q3 2025 in Review
Russell Investments Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 34,201 shares — an estimated $4.38M sold.
Russell Investments Group first reported a position in BPMC in Q4 2016 and held it in 35 quarters. The position peaked at $15M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Russell Investments Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Russell Investments Group sold 34,201 Blueprint Medicines shares in Q3 2025, an estimated $4.38M.
- Russell Investments Group first reported a position in Blueprint Medicines in Q4 2016 and held it in 35 quarters.
- Russell Investments Group's Blueprint Medicines position peaked at $15M in Q1 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.